CompuGroup Medical SE & Co. KGaA (COP.DE)
EUR 21.7
(0.37%)
EUR 21.7
(0.37%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 143.68 Million EUR | 3.69% |
| 2022 | 850.7 Million EUR | 11.45% |
| 2021 | 763.28 Million EUR | 29.9% |
| 2020 | 587.58 Million EUR | 13.84% |
| 2019 | 516.16 Million EUR | 16.1% |
| 2018 | 444.59 Million EUR | 9.8% |
| 2017 | 404.89 Million EUR | 4.5% |
| 2016 | 387.44 Million EUR | 0.38% |
| 2015 | 385.97 Million EUR | 1.31% |
| 2014 | 380.98 Million EUR | 13.8% |
| 2013 | 334.78 Million EUR | 8.48% |
| 2012 | 308.59 Million EUR | 8.08% |
| 2011 | 285.51 Million EUR | 25.6% |
| 2010 | 227.32 Million EUR | 6.0% |
| 2009 | 214.46 Million EUR | 35.08% |
| 2008 | 158.76 Million EUR | 32.46% |
| 2007 | 119.86 Million EUR | 1074.6% |
| 2006 | 10.2 Million EUR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 210.22 Million EUR | -10.34% |
| 2024 Q2 | 40.07 Million EUR | -95.96% |
| 2023 Q1 | 212.4 Million EUR | -3.39% |
| 2023 FY | 882.12 Million EUR | 3.69% |
| 2023 Q4 | 234.45 Million EUR | 10.55% |
| 2023 Q3 | 212.08 Million EUR | -4.97% |
| 2023 Q2 | 223.17 Million EUR | 5.07% |
| 2022 Q2 | 216.56 Million EUR | 6.09% |
| 2022 Q3 | 210.12 Million EUR | -2.97% |
| 2022 Q1 | 204.13 Million EUR | 0.14% |
| 2022 FY | 850.7 Million EUR | 11.45% |
| 2022 Q4 | 219.87 Million EUR | 4.64% |
| 2021 Q2 | 184.04 Million EUR | 2.63% |
| 2021 Q3 | 196.06 Million EUR | 6.53% |
| 2021 Q4 | 203.85 Million EUR | 3.98% |
| 2021 FY | 763.28 Million EUR | 29.9% |
| 2021 Q1 | 179.32 Million EUR | 10.33% |
| 2020 FY | 587.58 Million EUR | 13.84% |
| 2020 Q4 | 162.53 Million EUR | 6.68% |
| 2020 Q3 | 152.36 Million EUR | 11.9% |
| 2020 Q2 | 136.16 Million EUR | -0.26% |
| 2020 Q1 | 136.51 Million EUR | 3.74% |
| 2019 Q1 | 120.46 Million EUR | 4.09% |
| 2019 Q3 | 127.88 Million EUR | -2.9% |
| 2019 Q4 | 131.59 Million EUR | 2.9% |
| 2019 Q2 | 131.7 Million EUR | 9.33% |
| 2019 FY | 516.16 Million EUR | 16.1% |
| 2018 Q1 | 107.24 Million EUR | 1.74% |
| 2018 Q4 | 115.73 Million EUR | 4.4% |
| 2018 Q3 | 110.85 Million EUR | 0.09% |
| 2018 Q2 | 110.75 Million EUR | 3.28% |
| 2018 FY | 444.59 Million EUR | 9.8% |
| 2017 Q2 | 100.75 Million EUR | -0.46% |
| 2017 FY | 404.89 Million EUR | 4.5% |
| 2017 Q4 | 105.4 Million EUR | 8.09% |
| 2017 Q3 | 97.52 Million EUR | -3.2% |
| 2017 Q1 | 101.21 Million EUR | 2.17% |
| 2016 Q2 | 97.91 Million EUR | 2.48% |
| 2016 Q4 | 99.06 Million EUR | 4.37% |
| 2016 FY | 387.44 Million EUR | 0.38% |
| 2016 Q3 | 94.92 Million EUR | -3.06% |
| 2016 Q1 | 95.54 Million EUR | -5.43% |
| 2015 Q2 | 93.29 Million EUR | -0.11% |
| 2015 Q3 | 98.24 Million EUR | 5.3% |
| 2015 FY | 385.97 Million EUR | 1.31% |
| 2015 Q1 | 93.39 Million EUR | -12.27% |
| 2015 Q4 | 101.03 Million EUR | 2.84% |
| 2014 Q1 | 90.01 Million EUR | -0.28% |
| 2014 Q4 | 106.45 Million EUR | 17.24% |
| 2014 FY | 380.98 Million EUR | 13.8% |
| 2014 Q2 | 93.71 Million EUR | 4.11% |
| 2014 Q3 | 90.8 Million EUR | -3.11% |
| 2013 FY | 334.78 Million EUR | 8.48% |
| 2013 Q4 | 90.27 Million EUR | 12.27% |
| 2013 Q1 | 80.46 Million EUR | 3.34% |
| 2013 Q3 | 80.4 Million EUR | -3.86% |
| 2013 Q2 | 83.63 Million EUR | 3.94% |
| 2012 Q2 | 77.08 Million EUR | -1.05% |
| 2012 Q1 | 77.9 Million EUR | 8.21% |
| 2012 Q3 | 75.74 Million EUR | -1.74% |
| 2012 Q4 | 77.86 Million EUR | 2.8% |
| 2012 FY | 308.59 Million EUR | 8.08% |
| 2011 Q2 | 70.22 Million EUR | -0.82% |
| 2011 Q4 | 71.99 Million EUR | -0.69% |
| 2011 FY | 285.51 Million EUR | 25.6% |
| 2011 Q3 | 72.49 Million EUR | 3.23% |
| 2011 Q1 | 70.8 Million EUR | 14.2% |
| 2010 Q2 | 56.42 Million EUR | 4.42% |
| 2010 FY | 227.32 Million EUR | 6.0% |
| 2010 Q1 | 54.03 Million EUR | -11.75% |
| 2010 Q4 | 62 Million EUR | 13.03% |
| 2010 Q3 | 54.85 Million EUR | -2.78% |
| 2009 Q3 | 49.94 Million EUR | -7.26% |
| 2009 FY | 214.46 Million EUR | 35.08% |
| 2009 Q1 | 49.42 Million EUR | 0.0% |
| 2009 Q4 | 61.23 Million EUR | 22.59% |
| 2009 Q2 | 53.85 Million EUR | 8.97% |
| 2008 FY | 158.76 Million EUR | 32.46% |
| 2007 FY | 119.86 Million EUR | 1074.6% |
| 2006 FY | 10.2 Million EUR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| DocCheck AG | 9.43 Million EUR | -1423.43% |
| MeVis Medical Solutions AG | 558.96 Thousand EUR | -25605.146% |
| Nexus AG | 44.98 Million EUR | -219.4% |